Latest news
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million - Business WireBusiness Wire · Mon, 03 Aug 2026 13:00:00 GMTXFLT Board Urges Shareholders to Vote FOR Approval of King Street Sub-Adviser Ahead of August 6th Special Meeting - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:50:00 GMTOctagon Urges XFLT Shareholders to Stay the Course and Reject the New Sub-Adviser Proposal - Business WireBusiness Wire · Fri, 31 Jul 2026 19:49:00 GMTOctagon Denounces Decision by the Board of Trustees of XFLT to Delay the Shareholder Vote on the Proposed Sub-Adviser Transition - Business WireBusiness Wire · Thu, 30 Jul 2026 16:10:00 GMTXAI Floating Rate & Alternative Income Trust delays shareholder vote on sub-adviser transition - BitgetBitget · Thu, 30 Jul 2026 07:00:00 GMTGrowIt Selects Modern Treasury to Power Payments for Real Estate Capital Raises - Business WireBusiness Wire · Wed, 29 Jul 2026 16:00:00 GMTOctagon Criticizes XFLT Board’s Coercive Plan to Cajole Shareholders into Approving an Unfit Sub-Adviser for the Fund - Business WireBusiness Wire · Tue, 28 Jul 2026 11:00:00 GMTOctagon Calls on Fellow XFLT Shareholders to Vote AGAINST the Appointment of a New Sub-Adviser and Demand a Better Path Forward - Business WireBusiness Wire · Mon, 27 Jul 2026 12:30:00 GMT